EA201200196A1 - Составы для ухода за полостью рта, содержащие человеческий рекомбинантный интерлейкин-1 - Google Patents

Составы для ухода за полостью рта, содержащие человеческий рекомбинантный интерлейкин-1

Info

Publication number
EA201200196A1
EA201200196A1 EA201200196A EA201200196A EA201200196A1 EA 201200196 A1 EA201200196 A1 EA 201200196A1 EA 201200196 A EA201200196 A EA 201200196A EA 201200196 A EA201200196 A EA 201200196A EA 201200196 A1 EA201200196 A1 EA 201200196A1
Authority
EA
Eurasian Patent Office
Prior art keywords
human recombinant
recombinant interleukin
oral cavity
compositions
care
Prior art date
Application number
EA201200196A
Other languages
English (en)
Other versions
EA019332B1 (ru
Inventor
Игорь Артурович Петропавлов
Игорь Анатольевич Помыткин
Original Assignee
Юнайтед Текнолоджис Ут Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнайтед Текнолоджис Ут Аг filed Critical Юнайтед Текнолоджис Ут Аг
Publication of EA201200196A1 publication Critical patent/EA201200196A1/ru
Publication of EA019332B1 publication Critical patent/EA019332B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Данное изобретение относится к составам по уходу за полостью рта, в состав которых входит человеческий рекомбинантный интерлейкин-1 и его методы применения для поддержания полости рта в хорошем состоянии, уменьшения неприятного запаха из полости рта и/или профилактики или лечения заболеваний пародонта. Предпочтительно, чтобы человеческим рекомбинантным интерлейкином-1 являлся человеческий рекомбинантный интерлейкин-1 альфа или бета.
EA201200196A 2009-09-29 2009-09-29 Состав для ухода за полостью рта, содержащий человеческий рекомбинантный интерлейкин-1 EA019332B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/062639 WO2011038754A1 (en) 2009-09-29 2009-09-29 Oral care compositions containing human recombinant interleukin-1

Publications (2)

Publication Number Publication Date
EA201200196A1 true EA201200196A1 (ru) 2012-07-30
EA019332B1 EA019332B1 (ru) 2014-02-28

Family

ID=42715271

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201200196A EA019332B1 (ru) 2009-09-29 2009-09-29 Состав для ухода за полостью рта, содержащий человеческий рекомбинантный интерлейкин-1

Country Status (10)

Country Link
US (1) US20120219511A1 (ru)
EP (1) EP2464330B1 (ru)
JP (1) JP5661777B2 (ru)
KR (1) KR101533316B1 (ru)
CN (1) CN102573788B (ru)
BR (1) BR112012007399A2 (ru)
EA (1) EA019332B1 (ru)
TW (1) TWI478722B (ru)
UA (1) UA101459C2 (ru)
WO (1) WO2011038754A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9917885B2 (en) * 2013-07-30 2018-03-13 International Business Machines Corporation Managing transactional data for high use databases
KR101610861B1 (ko) * 2014-07-28 2016-04-11 (주)케어젠 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도
WO2017172955A1 (en) * 2016-03-29 2017-10-05 Safewhite, Inc. Polyelectrolyte dental adhesives for whitening teeth and teeth components

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
US4801686A (en) * 1986-09-04 1989-01-31 Immunex Corporation Purification of recombinant interleukin-1
EP0393140B1 (en) * 1987-12-18 1993-08-11 Immunex Corporation Topical wound-healing preparations comprising interleukin-1 proteins
US5202118A (en) * 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
ZA89202B (en) * 1988-01-15 1989-09-27 Hoffmann La Roche Recombinant human interleukin-1 alpha polypeptides
KR960008010B1 (ko) * 1988-07-29 1996-06-19 오오쓰까세이야꾸 가부시끼가이샤 IL-1α 유도체 및 혈소판 감소증 치료 약제
US5827534A (en) * 1995-05-24 1998-10-27 University Of Maryland At Baltimore Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
US6413760B1 (en) * 1997-04-15 2002-07-02 Genetics Institute, Inc. Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof
ID20480A (id) * 1997-10-02 1998-12-24 Lg Chemical Ltd Komposisi untuk mencegah atau mengobati penyakit periodontal yang terdiri dari ekstrak dari achyranthis radix atau ulmus cortex
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
JP2002200161A (ja) * 2000-10-24 2002-07-16 Menicon Co Ltd 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
EP1680064A1 (en) * 2003-09-18 2006-07-19 Smithkline Beecham Corporation Method of applying oral compositions
ATE433746T1 (de) * 2004-03-12 2009-07-15 Biodel Inc Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
DE602005025111D1 (de) * 2004-05-03 2011-01-13 Interleukin Genetics Inc Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheiten
JP2008511652A (ja) * 2004-08-27 2008-04-17 アドヴァンスド ヴァイラル リサーチ コーポレーション 創傷治癒の促進方法
US20080008663A1 (en) * 2006-07-10 2008-01-10 Wm. Wrigley Jr. Company Method of reducing inflammation
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system

Also Published As

Publication number Publication date
CN102573788B (zh) 2014-05-21
KR20120081593A (ko) 2012-07-19
CN102573788A (zh) 2012-07-11
KR101533316B1 (ko) 2015-07-03
EP2464330B1 (en) 2016-03-23
TWI478722B (zh) 2015-04-01
EP2464330A1 (en) 2012-06-20
WO2011038754A1 (en) 2011-04-07
EA019332B1 (ru) 2014-02-28
BR112012007399A2 (pt) 2016-08-09
UA101459C2 (ru) 2013-03-25
JP5661777B2 (ja) 2015-01-28
TW201117823A (en) 2011-06-01
JP2013505972A (ja) 2013-02-21
US20120219511A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
MX2011003473A (es) Composiciones para el cuidado bucal.
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
DOP2012000246A (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
NO20092637L (no) Fremgangsmater for behandling
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
EA200971053A1 (ru) Способы лечения кожных язв
MY160412A (en) Oral compositions containing extracts of zingiber officinale and related methods
EA201291336A1 (ru) Замещенные 5-фтор-1н-пиразолопиридины и их применение
MY164731A (en) Compound
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
BR112012015750A2 (pt) composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA201391119A1 (ru) Системы доставки наночастиц, их получение и применение
MY150829A (en) Oral compositions containing extracts of myristica fragrans and related methods
EA201200570A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
EA201171215A1 (ru) Стоматологическое анестезирующее средство для интраназального введения, содержащее тетракаин и вазоконстриктор
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
BRPI0907220A2 (pt) métodos de tratar distúrbios de perda óssea usando um antagonista de gm-csf
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
EA201200196A1 (ru) Составы для ухода за полостью рта, содержащие человеческий рекомбинантный интерлейкин-1
AU2017221784B2 (en) Novel compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM